Perspective Therapeutics (CATX) Tax Rate (2023)
Perspective Therapeutics (CATX) posted Tax Rate of 134.95% for Q4 2023, down 239.72% sequentially from 96.59% in Q1 2023.
Perspective Therapeutics (CATX) Tax Rate (2023) Analysis & Trends
Perspective Therapeutics has reported Tax Rate for 1 years, with the latest figure at 134.95% in Q4 2023.
- Quarterly Tax Rate changed N/A year-over-year to 134.95% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.03% (changed N/A YoY) and the FY2023 annual result came in at 0.02%, changed N/A from the prior year.
- Tax Rate eased to 134.95% in Q4 2023 per CATX's latest filing, from 96.59% in the prior quarter.
- Over five years, Tax Rate peaked at 96.59% in Q1 2023 and troughed at 134.95% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 39.11% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 18.41% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 31.35% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 53.56% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 21.54% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 17.17% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -21.74% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 26.51% |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -134.95% |
| Dec 31, 2023 | -134.95% |
| Dec 31, 2023 | -134.95% |
| Mar 31, 2023 | 96.59% |
| Mar 31, 2023 | 96.59% |
| Mar 31, 2023 | 96.59% |